Verve Therapeutics (NASDAQ:VERV) Price Target Cut to $15.00 by Analysts at Royal Bank of Canada
Verve Therapeutics (NASDAQ:VERV – Get Free Report) had its target price lowered by equities researchers at Royal Bank of Canada from $17.00 to $15.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s target price would suggest a […]
Verve Therapeutics (NASDAQ:VERV – Get Free Report) had its target price lowered by equities researchers at Royal Bank of Canada from $17.00 to $15.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s target price would suggest a […]
